Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;105(14):1063-1069.
doi: 10.1136/heartjnl-2018-314269. Epub 2019 Feb 12.

Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse

Affiliations

Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse

Simon Ermakov et al. Heart. 2019 Jul.

Abstract

Objective: Bileaflet mitral valve prolapse (MVP) with either focal or diffuse myocardial fibrosis has been linked to ventricular arrhythmia and/or sudden cardiac arrest. Left ventricular (LV) mechanical dispersion by speckle-tracking echocardiography (STE) is a measure of heterogeneity of ventricular contraction previously associated with myocardial fibrosis. The aim of this study is to determine whether mechanical dispersion can identify MVP at higher arrhythmic risk.

Methods: We identified 32 consecutive arrhythmic MVPs (A-MVP) with a history of complex ventricular ectopy on Holter/event monitor (n=23) or defibrillator placement (n=9) along with 27 MVPs without arrhythmic complications (NA-MVP) and 39 controls. STE was performed to calculate global longitudinal strain (GLS) as the average peak longitudinal strain from an 18-segment LV model and mechanical dispersion as the SD of the time to peak strain of each segment.

Results: MVPs had significantly higher mechanical dispersion compared with controls (52 vs 42 ms, p=0.005) despite similar LV ejection fraction (62% vs 63%, p=0.42) and GLS (-19.7 vs -21, p=0.045). A-MVP and NA-MVP had similar demographics, LV ejection fraction and GLS (all p>0.05). A-MVP had more bileaflet prolapse (69% vs 44%, p=0.031) with a similar degree of mitral regurgitation (mostly trace or mild in both groups) (p>0.05). A-MVP exhibited greater mechanical dispersion when compared with NA-MVP (59 vs 43 ms, p=0.0002). Mechanical dispersion was the only significant predictor of arrhythmic risk on multivariate analysis (OR 1.1, 95% CI 1.02 to 1.11, p=0.006).

Conclusions: STE-derived mechanical dispersion may help identify MVP patients at higher arrhythmic risk.

Keywords: cardiac arrest; echocardiography; mitral regurgitation; valvular heart disease; ventricular tachycardia.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Examples of Tomtec Image Arena measurements of global longitudinal strain (GLS) and time to peak strain (TTP) in arrhythmic mitral valve prolapse (A-MVP) patients (top panel) and non-arrhythmic mitral valve prolapse patients (NA-MVP) (bottom panel). Greater variability in the TTP of each left ventricular (LV) wall segment is seen in the A-MVP patients compared with the NA-MVP patients reflecting increased mechanical dispersion. GLS is defined as the average peak systolic strain for all 18 LV segments. Mechanical dispersion is defined as the SD of the time to peak strain in all 18 LV segments.
Figure 2
Figure 2
Comparison of mechanical dispersion between controls, all mitral valve prolapse patients (MVP total), arrhythmic MVP patients (A-MVP) and non-arrhythmic MVP patients (NA-MVP). A-MVP patients had significantly higher mechanical dispersion compared with controls (mean 59 vs 42 ms, p<0.001) and NA-MVP patients (mean 59 vs 43 ms, p<0.001). There was no difference in mechanical dispersion between the control and the NA-MVP groups (p=0.78).
Figure 3
Figure 3
Comparison of mechanical dispersion between arrhythmic mitral valve prolapse patients (A-MVP) treated with an implantable-cardioverter defibrillator (ICD) and A-MVP with complex ventricular ectopy on monitor (ComVE). Mechanical dispersion was higher in A-MVP treated with an ICD compared with A-MVP with ComVE (mean 67 vs 56 ms, p=0.078).

Comment in

References

    1. Freed LA, Levy D, Levine ra, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341:1–7. - PubMed
    1. Delling FN, Vasan RS. Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation 2014;129:2158–70. - PMC - PubMed
    1. Nishimura RA, Mcgoon MD, Shub C, et al. Echocardiographically documented mitral-valve prolapse. long-term follow-up of 237 patients. N Engl J Med 1985;313:1305–9. - PubMed
    1. Narayanan K, Uy-Evanado A, Teodorescu C, et al. Mitral valve prolapse and sudden cardiac arrest in the community. Heart Rhythm 2016;13:498–503. - PMC - PubMed
    1. Grigioni F, Enriquez-Sarano M, Ling LH, et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol 1999;34:2078–85. - PubMed

Publication types

MeSH terms